Assessment of Cellular and Tissue Characteristics in Lipoaspirates Stirred by VorFat

Overseen By Amy Kilian

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Alma Lasers

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 1

Duration: 1 day

Trial Summary

What is the purpose of this trial?

This trial is studying the LipoLife liposuction procedure, which removes fat from the body. It aims to understand how well the fat cells survive and their overall condition after being removed. The study involves patients who are having liposuction to get rid of excess fat.

Research Team

William Jason Martin, MD

Principal Investigator

Jason Martin, M.D.

Eligibility Criteria

Inclusion Criteria

The study requires at least 300 milliliters of fat to be collected.

Provided written Informed Consent.

You are planning to have a certain type of cosmetic surgery that involves removing fat from your abdomen and flanks, and you are willing to donate some of that fat for the study.

Exclusion Criteria

You have a history of an autoimmune disorder like Systemic Lupus Erythematosus (SLE).

The investigator believes that you cannot safely participate in the study due to some other reason.

Pregnant or intending to become pregnant during the course of study.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo laser-assisted liposuction with the LipoLife system

1 day

1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

6 months

Treatment Details

Interventions

• LipoLife system

Participant Groups

Group I: Laser-assisted liposuction Experimental Treatment 1 Intervention

Laser-Assisted Liposuction with the LipoLife system.

Who Is Running the Clinical Trial?

Alma Lasers

Lead Sponsor

Trials

10

Recruited

220+